C M Perkins - JoVE Visualize

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1989

The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patientsC M Airey, D E Price, J V Kemp, et al.

Clinical Chemistry|February 1, 1985

A sensitive high-temperature electrothermal atomic absorption analysis for Rb+ in erythrocytes and plasma of normal and hypertensive personsK F Hallis, N A Boon, C M Perkins, et al.

Chemosphere|June 1, 1997

Biodegradation of [S,S], [R,R] and mixed stereoisomers of ethylene diamine disuccinic acid (EDDS), a transition metal chelatorD Schowanek, T C Feijtel, C M Perkins, et al.

Diabetologia|July 1, 1987

Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patientsP J Hale, M Nattrass, S H Silverman, et al.

Nature|December 25, 1980

Growth-modulating plasma tripeptide may function by facilitating copper uptake into cellsL Pickart, J H Freedman, W J Loker, et al.

Clinical Science (London, England : 1979)|July 1, 1984

A paradoxical fall in urine dopamine output when patients with essential hypertension are given added dietary saltJ N Harvey, I F Casson, A D Clayden, et al.

Diabetes, Obesity & Metabolism|August 27, 2014

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metforminJ Reusch, M W Stewart, C M Perkins, et al.

Allergy|May 29, 2014

Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459R Pettipher, M G Hunter, C M Perkins, et al.

Allergy|October 3, 2012

The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trialF Horak, P Zieglmayer, R Zieglmayer, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 19, 2011

A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthmaN Barnes, I Pavord, A Chuchalin, et al.

Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1989

The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patientsC M Airey, D E Price, J V Kemp, et al.

Clinical Chemistry|February 1, 1985

A sensitive high-temperature electrothermal atomic absorption analysis for Rb+ in erythrocytes and plasma of normal and hypertensive personsK F Hallis, N A Boon, C M Perkins, et al.

Chemosphere|June 1, 1997

Biodegradation of [S,S], [R,R] and mixed stereoisomers of ethylene diamine disuccinic acid (EDDS), a transition metal chelatorD Schowanek, T C Feijtel, C M Perkins, et al.

Diabetologia|July 1, 1987

Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patientsP J Hale, M Nattrass, S H Silverman, et al.

Nature|December 25, 1980

Growth-modulating plasma tripeptide may function by facilitating copper uptake into cellsL Pickart, J H Freedman, W J Loker, et al.

Clinical Science (London, England : 1979)|July 1, 1984

A paradoxical fall in urine dopamine output when patients with essential hypertension are given added dietary saltJ N Harvey, I F Casson, A D Clayden, et al.

Diabetes, Obesity & Metabolism|August 27, 2014

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metforminJ Reusch, M W Stewart, C M Perkins, et al.

Allergy|May 29, 2014

Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459R Pettipher, M G Hunter, C M Perkins, et al.

Allergy|October 3, 2012

The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trialF Horak, P Zieglmayer, R Zieglmayer, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 19, 2011

A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthmaN Barnes, I Pavord, A Chuchalin, et al.

Pageof 2